A lamellar macular hole is a small, shallow split or missing piece of tissue in the inner layers of the macula (the sharp-vision center of your retina). Think of the macula as a thin, layered film. In LMH, the top layers are partly scooped out, but the bottom layers are still intact. Because the retina isn’t completely open from top to bottom, vision loss is often milder than in a full-thickness macular hole. On OCT scans, LMH shows an irregular foveal contour, a foveal cavity with undermined edges, and apparent loss of foveal tissue; optional features include a foveal bump, epiretinal proliferation, and ellipsoid-zone disruption. eScholarship
A lamellar macular hole is a partial-thickness split or gap in the very center of the retina called the fovea.
Retina = the thin, light-sensing layer at the back of the eye.
Macula = the small, central area of the retina responsible for sharp, detailed vision (reading, faces).
Fovea = the tiny pit in the macula that gives our highest-resolution vision.
In LMH, only some layers of the fovea are separated or missing. The split does not go all the way through the retina. That’s why LMH is different from a full-thickness macular hole (FTMH), where the hole runs through the entire retina at the fovea. Because LMH is partial, vision is often blurred or distorted but usually not as severely as in a full hole.
How does a lamellar macular hole form?
Two broad mechanisms explain most LMHs:
Traction (pulling): As we age, the vitreous gel shrinks and separates from the retina (PVD). If the gel or an epiretinal membrane (ERM) tugs on the delicate fovea, it can split the inner layers and change the foveal shape, creating a lamellar-type split. Think of lifting a corner of cling film—some layers wrinkle or split while others stay stuck.
Degenerative tissue loss (thinning): In some eyes, the central retina gradually thins and forms schisis-like (split) cavities. A special soft tissue called LHEP may form on the surface. This is less about pulling and more about progressive weakening and reshaping of the foveal layers.
In many patients, both mechanisms mingle to different degrees.
Types of lamellar macular hole
Tractional LMH
Main idea: The retina is pulled by an ERM or lingering vitreous attachments.
On OCT: Steeper edges, a “scooped-out” inner defect, often with a visible ERM causing surface wrinkling.
Symptoms: Distortion (wavy lines), mild-to-moderate central blur.
Degenerative LMH
Main idea: The retina thins and splits more from tissue loss than pulling.
On OCT: Schisis-like (split) cavities, a rounder foveal contour, and often LHEP covering the surface.
Symptoms: Gradual blurring; distortion may be milder; changes can be slow.
Mixed LMH
Main idea: Has features of both traction and degeneration.
On OCT: Combination of ERM traction plus degenerative splits and LHEP.
Symptoms: Mixed picture—distortion and blur.
Related entity: Macular pseudohole (not a true LMH)
Main idea: An ERM constricts the fovea to make a hole-like appearance, but the retina is not split.
On OCT: Narrow, steep foveal pit, intact outer layers.
Why mention: Pseudohole can look like LMH in photos, but OCT separates them.
Causes and contributors
Aging and PVD
With age, the vitreous peels away from the retina. If it tugs the fovea during this process, a lamellar split can form.Epiretinal membrane (ERM)
A thin surface film can shrink and wrinkle the macula, pulling on it and shaping a lamellar gap.Lamellar hole–associated epiretinal proliferation (LHEP)
A softer, glial sheet over the macula that goes with degenerative LMH, promoting thinning and splitting.Vitreomacular traction (VMT)
Partial sticking of the vitreous to the macula creates focal pulling, encouraging a lamellar split.High myopia (severe nearsightedness)
A longer, stretched eye leads to thinning in the macula; small splits can form more easily.Blunt eye trauma
A hit to the eye can shear the foveal layers and trigger a lamellar-type defect.Prior eye surgery (e.g., cataract)
Post-op inflammation or ERM formation can reshape the macula and contribute to LMH.Cystoid macular edema (CME)
Multiple tiny fluid pockets can weaken the foveal layers; over time, a split can remain.Diabetic macular changes
Diabetes can cause edema and ERM, both of which increase the chance of an LMH.Macular telangiectasia type 2
Abnormal tiny vessels near the fovea can thin the retina and contribute to lamellar changes.Age-related macular degeneration (AMD)
Macular thinning or scarring in some AMD patterns can favor a lamellar split.Central serous chorioretinopathy (CSC)
Repeated fluid under the macula can alter foveal structure, leaving residual splits.Uveitis (intraocular inflammation)
Inflammation can lead to ERM and macular edema, both setting the stage for LMH.Vitreoschisis (split within the vitreous gel)
A partial peel leaves sticky layers behind, creating unpredictable traction on the fovea.Radiation retinopathy
After ocular or head/neck radiation, macular edema and ischemia can promote ERM and splits.Retinal vein occlusion (RVO)
Macular swelling after a vein blockage weakens retinal layers; LMH can follow.Retinal dystrophies
Inherited retinal thinning conditions can make a lamellar split more likely.Solar or laser maculopathy
Light/thermal injury can damage the foveal tissue and leave a partial-thickness defect.Epiretinal prosthesis or prior macular procedures
Any prior manipulation of the central retina may cause scarring/ERM that reshapes the fovea.Idiopathic (no clear trigger)
Sometimes an LMH appears without a single obvious cause, likely due to subtle combined factors.
Symptoms
Central blur – the “sweet spot” of vision isn’t sharp.
Metamorphopsia – straight lines look bent or wavy.
Difficulty reading small print – letters fuse, wobble, or fade.
A small gray or dull area – a faint smudge near fixation.
Reduced contrast – harder to see pale text on gray backgrounds.
Micropsia – words or faces look slightly smaller.
Trouble recognizing faces – fine details are off.
Needing brighter light – more light to reach the same clarity.
Monocular double image – ghosting with one eye.
Eye strain – extra effort to hold focus on small targets.
Fluctuating clarity – some days sharper, some days worse.
Color dulling – colors seem a bit washed out centrally.
Distorted Amsler grid – boxes look warped when tested.
Depth-perception issues – close tasks feel clumsier if one eye is worse.
Headache from visual effort – nonspecific but common when reading is hard.
Note: Pain, redness, or sudden large vision loss suggest something else or a new problem and need urgent care.
Diagnostic tests
A) Physical exam
External and slit-lamp exam of the front of the eye
The doctor checks lids, cornea, lens, and anterior chamber to look for surgery signs, inflammation, or other issues that might contribute to macular problems. Slit-lamp means a bright microscope that gives a magnified, 3-D view.Pupil examination (light reflex, RAPD)
Pupils are checked to ensure the optic nerve is working properly. LMH usually does not cause an abnormal relative afferent pupillary defect (RAPD). A normal pupil response supports a macular (retinal center) problem rather than a major optic-nerve issue.Intraocular pressure (IOP) measurement
A quick, painless tonometry reading. While not specific for LMH, it’s part of a full eye health check, because pressure problems (glaucoma) can coexist and influence management choices.Dilated fundus examination with slit-lamp biomicroscopy
After dilating drops, the doctor examines the macula directly with special lenses. An LMH may show a shallow central depression, irregular foveal contour, and often ERM or LHEP. This exam guides which imaging to order next.
B) Manual tests
Best-corrected visual acuity (BCVA)
Reading letters on a chart (Snellen or ETDRS) with updated glasses gives a baseline of central vision. LMH often causes mild-to-moderate loss (for example, 20/25 to 20/60), but ranges vary.Amsler grid
A simple square grid viewed at reading distance. LMH commonly produces wavy or missing boxes at the center. It’s a handy home monitor too—new changes can signal progression.Refraction and pinhole test
Ensures blur is not mainly from glasses error or cataract. The pinhole improves focus if the cornea/lens is the problem; less improvement points to a retinal cause such as LMH.Watzke–Allen test
A thin slit of light is projected across the fovea. Patients with macular holes sometimes see the line as broken or thinner in the center. In LMH the effect can be subtle (often “thinned” rather than “broken”), helping distinguish from full holes.Photostress recovery test
A bright light briefly “bleaches” the macula. In macular disease, recovery to pre-bleach reading speed is delayed. This supports that the problem is in the macula rather than the optic nerve.
C) Laboratory and pathological tests
Labs are not required for most typical LMH, but can help when history suggests other diseases that mimic or worsen macular problems.
Hemoglobin A1c
Checks 3-month average blood sugar. Diabetes can cause macular swelling and ERM, increasing the risk of an LMH or making symptoms worse.Fasting plasma glucose
Screens for diabetes or prediabetes if not already known. Helps explain coexisting macular edema.Lipid panel
High cholesterol can relate to retinal vascular issues (e.g., vein occlusions) that lead to macular swelling and secondary LMH.Inflammation markers (ESR and CRP)
If uveitis or systemic inflammation is suspected (redness, pain, floaters), these tests support the workup for inflammatory causes of macular changes.
D) Electrodiagnostic tests
Multifocal electroretinography (mfERG)
Records tiny electrical signals from many small retinal spots. In LMH, signals from the central area can be reduced, confirming localized macular dysfunction.Pattern ERG (pERG)
Evaluates macular and ganglion cell function using patterned visual stimuli. Abnormalities can quantify how much the central retina is affected beyond what the eye chart shows.Visual evoked potential (VEP)
Measures the brain’s response to visual patterns. Usually normal or mildly affected in LMH, VEP helps rule out major optic-nerve or brain pathway causes for vision loss.
E) Imaging tests
Optical coherence tomography (OCT)
Key test. OCT shows cross-sections of the macula at micron resolution. It can confirm LMH, show whether it’s tractional (ERM pulling) or degenerative (schisis-like splits, LHEP), measure size, and track change over time.Fundus photography
Color photos document the macula’s appearance (wrinkling, pseudohole look, ERM sheen). Helpful for before-and-after comparisons.OCT angiography (OCTA)
A dye-free scan of macular blood flow. In LMH it’s usually near normal but can show subtle changes in the foveal avascular zone or coexisting diseases (e.g., telangiectasia).Fluorescein angiography (FA)
A dye test that images retinal circulation. Not always needed for LMH, but useful if there’s suspicion of macular edema, telangiectasia, or other vascular problems that affect management.
Non-pharmacological treatments
Important: No eye drop or pill has been proven to close an LMH. Many people are safely observed unless vision is notably affected or OCT shows clear worsening. When needed, vitrectomy (eye surgery) is considered (details below). The steps here are supportive, comfort-focused, or preventive.
Observation with scheduled follow-up
For stable, mildly symptomatic LMH. Your doctor monitors OCT and vision, stepping in only if things change. Purpose: avoid unnecessary surgery. Mechanism: natural course is often slow; careful watching reduces risk of overtreatment. ophthalmologyretina.orgPatient education + monocular Amsler monitoring
Purpose: catch early changes. Mechanism: you note new distortion or blur and report promptly.Optimize glasses / refraction
Purpose: ensure blur isn’t partly from uncorrected refractive error. Mechanism: sharpen optical focus to uncover the true retinal limit.High-contrast reading strategies
Purpose: make letters “pop.” Mechanism: strong contrast (black text, matte white background) improves legibility.Task lighting and anti-glare
Purpose: reduce scatter and shadows. Mechanism: directed light and anti-glare filters increase contrast and comfort.Larger print, e-readers, zoom software
Purpose: reduce strain. Mechanism: magnification overcomes small central defects.Optical magnifiers (hand/stand/clip-on)
Purpose: enlarge detail for crafts, labels. Mechanism: simple optics boost retinal image size.Electronic video magnifiers (CCTV) and screen magnification apps
Purpose: flexible magnification & contrast. Mechanism: digital processing adapts content to your comfort.Low-vision rehabilitation
Purpose: teach practical techniques (eccentric viewing, reading strategies). Mechanism: trains you to use slightly “off-center” retina more efficiently.Blue-light and glare management
Purpose: reduce perceived haze. Mechanism: coatings/filters decrease scatter and discomfort (comfort, not cure).Treat co-existing dry eye
Purpose: improve image quality on the cornea. Mechanism: stable tear film reduces fluctuating blur.Smoking cessation
Purpose: protect macular health overall. Mechanism: lowers oxidative stress and vascular risk.Blood pressure, cholesterol, and blood sugar control
Purpose: protect retinal microcirculation and reduce edema risk. Mechanism: healthier vessels support macular function.Weight management and regular exercise
Purpose: cardiovascular health → retinal health. Mechanism: improves perfusion and reduces systemic inflammation.UV-blocking sunglasses
Purpose: general macular protection outdoors. Mechanism: filters high-energy light.Ergonomic setups (reading distance, posture)
Purpose: reduce strain and improve performance. Mechanism: steadier fixation and better lighting.Stress & sleep hygiene
Purpose: reduce eye strain and fatigue. Mechanism: better tear film and fixation stability.Careful observation during cataract planning
Purpose: cataract surgery can unmask macular issues; coordinating care avoids surprises. Mechanism: pre-op OCT.Shared decision-making consult for surgery
Purpose: align expectations with likely benefits/risks; review OCT subtype (tractional vs degenerative). Mechanism: informed choice improves outcomes. NaturePost-operative positioning coaching (if surgery is chosen)
Purpose: help gas tamponade work effectively. Mechanism: guided face-down or tailored positioning supports foveal reapposition (surgeon-specific). (More under “Surgeries.”)
Drug treatments
Key message: There is no medication proven to close a lamellar macular hole. Medicines are used to treat associated problems (like inflammation or macular edema), to prepare for/after surgery, or to manage coexisting diseases. Ocriplasmin is not indicated for LMH and has even been reported to precipitate lamellar defects in rare cases; it is used for vitreomacular adhesion and some small full-thickness macular holes, not for LMH. New England Journal of MedicinePMC
Topical NSAIDs (e.g., ketorolac 0.5%, nepafenac 0.1%, bromfenac 0.07%)
Dose: 1 drop 2–4×/day (weeks, per doctor).
Purpose: calm macular edema/inflammation if present.
Mechanism: COX inhibition reduces prostaglandins in the retina.
Side effects: stinging, rare corneal issues with prolonged use.Topical corticosteroids (e.g., prednisolone acetate 1%, loteprednol 0.5%)
Dose: 1 drop QID then taper.
Purpose: treat inflammation or post-op quieting.
Mechanism: suppresses inflammatory pathways.
Side effects: ↑intraocular pressure, cataract acceleration (with longer use).Oral carbonic anhydrase inhibitor (acetazolamide 250 mg once–twice daily, short course)
Purpose: off-label to reduce secondary macular edema in select cases.
Mechanism: changes fluid transport across the retinal pigment epithelium (RPE).
Side effects: tingling, fatigue, kidney stones; avoid in sulfa allergy.Intravitreal corticosteroid (e.g., triamcinolone or dexamethasone implant)
Purpose: treat stubborn CME coexisting with LMH, not LMH itself.
Mechanism: local anti-inflammatory effect.
Side effects: pressure rise, cataract (phakic), infection risk (very low but serious).Anti-VEGF injections (e.g., ranibizumab, aflibercept)
Purpose: only if there’s coexisting choroidal neovascularization or edema from another disease; not for plain LMH.
Mechanism: blocks VEGF-driven leakage/growth.
Side effects: rare infection, transient pressure spike.Antibiotic drops (peri-operative)
Purpose: reduce surgical infection risk (surgeon-specific protocols).
Mechanism: topical microbe suppression.
Side effects: irritation, allergy (rare).Cycloplegic/mydriatic drops (short-term)
Purpose: comfort if significant ciliary spasm after procedures.
Mechanism: relaxes focusing muscle.
Side effects: light sensitivity, blurred near vision temporarily.Lubricating tears / gels
Purpose: improve optical quality if dry eye contributes to fluctuation.
Mechanism: stabilizes tear film.
Side effects: minimal.Analgesics (oral acetaminophen)
Purpose: post-procedure comfort; no effect on the hole.
Mechanism: central pain relief.
Side effects: liver risk at high doses.(What about ocriplasmin?)
Not recommended for LMH. It is for vitreomacular adhesion and some small full-thickness holes, and rare cases of LMH after ocriplasmin have been reported. Decisions are individualized and typically exclude LMH. New England Journal of MedicinePMC
Dietary & supportive supplements
Supplements can support overall retinal health, but none has proven to heal or close an LMH. Discuss any supplement with your doctor, especially before surgery or if you take blood thinners.
Lutein (10 mg/day) – macular pigment carotenoid; filters blue light and may improve contrast sensitivity over time.
Zeaxanthin (2 mg/day) – partners with lutein in the fovea; antioxidant support.
Meso-zeaxanthin (10 mg/day) – optional third carotenoid; may further thicken macular pigment.
AREDS2-style formula – vitamin C (500 mg), vitamin E (400 IU), zinc (80 mg as zinc oxide) + copper (2 mg), lutein/zeaxanthin; designed for AMD, not LMH, but supports antioxidant status.
Omega-3s (DHA/EPA 1–2 g/day) – anti-inflammatory lipid mediators; general retinal health.
Coenzyme Q10 (100–200 mg/day) – mitochondrial support/antioxidant.
N-acetylcysteine (600–1200 mg/day) – glutathione precursor; combats oxidative stress.
Resveratrol (100–250 mg/day) – polyphenol; antioxidant/anti-inflammatory actions (evidence in eyes is limited).
Curcumin (with piperine or optimized forms, 500–1000 mg/day) – systemic anti-inflammatory potential; ocular evidence limited.
Bilberry/anthocyanins (80–160 mg twice daily) – may aid night/contrast perception; clinical data variable.
Vitamin D (per labs, often 1000–2000 IU/day) – general immune modulation; low levels are common.
Magnesium (200–400 mg/day) – vascular and neural support; check kidney function.
B-complex (esp. B12/folate in deficiency) – supports neural metabolism.
Alpha-lipoic acid (300–600 mg/day) – antioxidant; small studies in diabetic eye disease.
Proanthocyanidins (grape seed extract 100–300 mg/day) – additional antioxidant support.
(Again, these are supportive; evidence focuses on retinal health, not LMH closure.)
Regenerative / stem-cell
There are no approved immune-boosting or stem-cell drugs for LMH. The options below are experimental or surgical adjuncts and should only be considered in clinical trials or in surgeon-guided situations.
Autologous platelet concentrate (APC) as a surgical adjunct
Used sometimes in macular surgery to promote hole closure in other settings; not standard for LMH. It supplies growth factors; evidence for LMH is limited.Inverted or free ILM flap techniques (surgical, not a drug)
“Regenerative” in concept because they provide a scaffold for tissue to grow over; used cautiously in degenerative LMH to protect the fragile fovea.Biologic glues or tissue sealants (adjunct, rare)
Aim to stabilize the fovea post-peel; investigational for LMH.Mesenchymal stem cells (MSCs), intravitreal or subretinal
Experimental only for retinal diseases; potential risks include inflammation, membranes, and vision loss. Not recommended outside trials.iPSC-derived photoreceptor/RPE transplantation
Cutting-edge research for degenerative retinal disorders; not an LMH therapy today.Neurotrophic factors / gene-based trophic support
Early research stage in other retinal diseases; no clinical role in LMH yet.
Surgeries
Surgery is considered when vision is meaningfully affected, symptoms are bothersome, or OCT shows clear progression. Modern approaches try to relieve traction while protecting the delicate fovea, especially in degenerative LMH. Overall, carefully selected patients can gain anatomic and visual improvement. ophthalmologyretina.orgPMC
Pars plana vitrectomy (PPV) with ERM & ILM peel
Procedure: Three tiny ports in the white of the eye; remove the vitreous gel; peel the epiretinal membrane and then the inner limiting membrane using micro-forceps (dye helps visualize). A small gas bubble may be placed.
Why: Releases traction and smooths the fovea to reduce distortion and improve vision. Best suited to tractional LMH. NatureFovea-sparing ILM peel
Procedure: Peel the ILM around the fovea but leave a tiny central island untouched.
Why: In degenerative LMH, leaving central ILM may lower the risk of converting to a full-thickness hole while still relieving surrounding traction. Comparative studies continue to refine when to use this. ophthalmologyretina.orgScienceDirectILM flap (inverted or embedded) technique
Procedure: Create a flap of ILM and invert or tuck it over the foveal defect after ERM removal.
Why: Provides a biologic scaffold over fragile tissue—used selectively for degenerative LMH with significant tissue loss. Evidence is evolving. ophthalmologyretina.orgScienceDirectGas tamponade (SF6 or C3F8) with tailored positioning
Procedure: At the end of PPV, a small gas bubble supports the fovea; some surgeons advise face-down or modified positioning for several days.
Why: Encourages the layers to settle and heal in place. Protocols vary by surgeon and case type. PMCCombined cataract surgery + vitrectomy (phacovitrectomy)
Procedure: Cataract removal with lens implant is done at the same sitting as PPV.
Why: Many patients will develop or already have cataract; combining surgeries can speed visual recovery and avoid a second operation.
Prevention tips
While you can’t guarantee prevention, you can lower risks for macular problems and make early care easier:
Regular dilated eye exams, especially after age 50 or if you have ERM.
Report new metamorphopsia or central blur quickly.
Don’t smoke; seek help to quit.
Manage diabetes, blood pressure, and lipids well.
UV protection outdoors (sunglasses, hats).
Use protective eyewear for sports/DIY to avoid trauma.
Eat a retina-friendly diet (leafy greens, colorful veggies, fish).
Stay active for vascular health.
Treat dry eye to improve day-to-day visual quality.
Coordinate cataract planning with a macula check (pre-op OCT).
When to see a doctor
New or worsening wavy lines on Amsler or reading.
Sudden drop in central clarity.
New central gray spot or enlarging “missing” area.
After eye trauma, even if symptoms seem mild.
Before and after cataract surgery if you already have macular disease.
Any time you notice a big change in one eye compared with the other.
Urgently if you see flashes, many new floaters, or a curtain in your vision (possible retinal tear/detachment—emergency).
What to eat and what to avoid
What to eat more:
Leafy greens (spinach, kale), bright vegetables (peppers, carrots) → carotenoids and vitamin C.
Oily fish 2–3×/week (salmon, sardines, mackerel) → omega-3s.
Citrus, berries, kiwi → vitamin C and polyphenols.
Nuts and seeds (almonds, walnuts, flax) → vitamin E and healthy fats.
Whole grains & legumes → steady blood sugar, vascular health.
Water → good tear film and overall health.
What to limit/avoid:
Smoking (strongest “avoid”).
Excess alcohol (can worsen nutrition and sleep).
Highly processed, high-salt foods if you have blood pressure issues.
Very high-glycemic carbs (large sugar spikes can aggravate retinal vascular stress).
Unvetted supplements before surgery or with blood thinners (e.g., high-dose ginkgo, fish oil) without asking your doctor.
Frequently asked questions
Is LMH the same as a macular hole?
No. LMH is partial-thickness; a full-thickness macular hole goes through all layers. LMH is usually less severe. American Academy of OphthalmologyCan an LMH close on its own?
Some remain stable, some worsen slowly; spontaneous full closure is uncommon. Doctors often observe unless vision drops or OCT worsens. ophthalmologyretina.orgWill eye drops fix it?
No drops are proven to close LMH. Drops can help inflammation or edema if present.When is surgery recommended?
When symptoms are troublesome or OCT shows progression (especially tractional LMH). Decision depends on your subtype and goals. Natureophthalmologyretina.orgWhat improvements can I expect from surgery?
Many patients gain clearer, less distorted vision; results vary by subtype, pre-op vision, and whether outer retinal layers are intact. ophthalmologyretina.orgIs there a risk the surgery makes it a full-thickness hole?
Rarely, yes—especially in degenerative LMH. That’s why surgeons may use fovea-sparing or flap techniques in selected cases. ophthalmologyretina.orgWill I need to face-down after surgery?
Sometimes, depending on gas use and surgeon preference. Many LMH cases require less strict positioning than full-thickness holes. PMCDoes ocriplasmin help LMH?
No—not indicated for LMH; it’s for vitreomacular adhesion and some small full-thickness holes. Rare LMH formation after ocriplasmin has been reported. New England Journal of MedicinePMCCan glasses or magnifiers help?
They won’t fix the hole, but they can improve day-to-day function and comfort.Is LMH an emergency?
No, but new severe symptoms (flashes/floaters/curtain) are emergencies for other reasons.Will I go blind from LMH?
LMH usually affects central detail but does not cause total blindness. Many remain stable or improve with surgery when needed. ophthalmologyretina.orgCan diet help?
Diet supports overall retinal health, but it won’t close LMH. Still, a leafy-greens + fish pattern is smart for eyes.Is LMH common in both eyes?
It can be unilateral or bilateral; your doctor will monitor the fellow eye with exams and sometimes OCT.What if I also have cataract?
Cataract and LMH commonly coexist with age. Your surgeon may suggest combined surgery to streamline recovery.How often should I be checked?
Depends on stability—often every 3–12 months with OCT when stable, sooner if symptoms change.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: August 10, 2025.
